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The Effect of Chronic Sleep Deprivation on Tumor Necrosis Factor 
Alpha and Bone Health in Peri-Menopausal Rats 
 
Introduction!
 Osteoporosis is a very common progressive 
skeletal disease in which the microarchitecture of 
bone tissue is slowly deteriorated causing a 
decrease in bone mineral density (BMD) and an 
increase in bone fragility. The cessation of 
estrogen signaling after menopause causes an 
imbalance between the osteoblasts which form 
bone, and osteoclasts, which degrade bone. 
Post-menopausal osteoporosis affects one in four 
women in which about one third of those women 
will experience a fracture due to the disease in 
their lifetime. 
 Chronic sleep deprivation (receiving less than 
six and a half hours of sleep a night) has been 
found to exacerbate osteoporosis. Through the 
production of an inflammatory response caused 
by chronic sleep deprivation, pro-inflammatory 
cytokines such as tumor necrosis factor alpha 
(TNF-α) and interleukin one (IL-1) increase 
osteoclastic activity, thus increasing bone 
degradation and decreasing BMD. A preventative 
drug known as Zolendronate, a bisphosphonate, 
is used to decrease osteoclastic activity.  
 This study evaluates the concentration of a 
cytokine, tumor necrosis factor alpha (TNF-α), 
and the effects of Zolendronate on the relative 
bone strength of female, ovariectomized (OVX) 
Wistar rats subjected to a five-week sleep 
deprivation protocol. 
Conclusions!
!Significant changes in overall bone strength 
were not found as a result of sleep deprivation or 
Zolendronate injection, over the course of this 
five-week study. The lack of significant changes 
may be attributed to the short time frame of the 
study. While five weeks has proven to be 
sufficient time to induce chronic sleep deprivation 
and to allow Zolendronate to effect bone 
remodeling it was not a long enough time frame 
for mechanical testing to show the differences in 
bone metabolism and architecture.  
 There was a significant difference in the 
serum concentrations of TNF-α among the 
experimental groups. TNF-α levels were 
significantly higher in the Zol group than both the 
control and SD, and SDZ groups (p<0.01). The 
high cytokine concentration in the Zol group may 
be due to the fact that Zolendronate has been 
shown to induce a transient fever in humans for 
twenty-one days after injection. Therefore, it may 
be possible that the measured cytokine level for 
the Zol group may represent residual amounts of 
the TNF-α present after the initial immune 
response to the drug. 
  While it was expected that the SD and SDZ 
groups would have elevated TNF-α 
concentrations due to sleep deprivation, the TNF-
α concentrations of the SD and SDZ were 
comparable to those of the control group. This 
may be attributable to a possible exhaustion of 
the animals’ immune systems. These findings 
warrant further research measuring the changes 
in cytokine concentration throughout a longer 
sleep deprivation protocol to determine the 
fluctuations of TNFα due to sleep deprivation and 
Zolendronate and their effect on mechanical 
difference in bone strength. 
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Methods 
 Thirty-two female ovariectomized Wistar rats 
were obtained and randomly placed in Control, 
Zolendronate (Zol), Sleep Deprived (SD), and 
Sleep Deprived with Zolendronate (SDZ) groups. 
Prior to experimental protocol the rats were 
injected with either saline or Zolendronate (Table 
1) and then given a one-week adaption period. 
Starting at 14:00 each day all rats were placed in 
their respected tanks (Table 1) where the SD and 
SDZ groups would undergo sleep deprivation and 
the Control and Zol groups would socialize. The 
SD and SDZ groups were subjected to one of 
three random sleep cycles (Table 2) each night 
for five weeks to stimulate irregular sleep cycles 
experienced by many post-menopausal women. 
During the scheduled time the SD and SDZ 
groups were being sleep deprived, the Control 
and Zol groups were able to socialize and sleep 
freely in the control tank. 
Results!
All data were treated by Analysis of Variance (ANOVA). Significance was accepted at p<.01. A Newman-Keuls post hoc 
test was employed to identify the significantly different group. 
3-Point Bending Test 
A 3-point bending task was performed on each of the 
animals’ left femurs. The data is displayed In Figure 2. 
These data show no significant differences in bone strength 
among the groups.  
TNF-α Concentration!
An ELISA was performed to determine serum 
concentrations of TNF-α (pg/mL). The data is displayed in 
Figure 3. The Zolendronate group is the only group of 
significance. 
 After undergoing the designated amount of sleep 
deprivation/socialization all rats were placed back into their 
individual cages and allowed to sleep for the allotted amount 
of time based off a random number generator. Food and 
water were available ad libitum for all groups during the 
entire protocol.  
 
 TNF-α plasma concentrations were determined by 
enzyme-linked immunosorbent assay (ELISA). Bone 
strength, area gradient and area were determined via a 
three point bending test.  
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Figure 2: Average Bone Strength per Experimental Group. Figure 3: Average TNF-a Concentration per Experimental. 
Group 
*Significance determined p<0.01. 
Group Name # of Rats Injection Sleep Deprived MMPM Tank 
Control 5 0.45mL 0.9% saline No 1 (control) 
Zol 9 50ug/kg Zolendronate No 1 (control) 
SD 9 0.45mL 0.9% saline Yes 2 
SDZ 9 50ug/kg Zolendronate Yes 3 
Table 1: Experimental Groups and Treatments. 
Sleep Cycle Time Awake 
(hours) 
Time Allowed for 
Sleep (hours) 
Start Time End Time 
SC1 19 5 14:00 9:00 
SC2 18 6 14:00 8:00 
SC3 17 7 14:00 7:00 
Table 2: Variable Sleep Cycles.. 
Figure 1: Multiple Modified Platform Tank Design. 
 Two Multiple Modified Platform (MMP) tanks, housing 
each the sleep deprived (SD) or sleep deprived and 
Zoledronate (SDZ) groups, were constructed according to 
the dimensions found in Figure 1. A third tank, lacking 
platforms and surrounding water, was used to house rats in 
the control (Con) and Zoledronate (Zol) groups.  
 
